149 related articles for article (PubMed ID: 38411778)
41. The Utility of Risk Factors to Define Complicated Staphylococcus aureus Bacteremia in a Setting With Low Methicillin-Resistant S. aureus Prevalence.
van der Vaart TW; Prins JM; Goorhuis A; Lemkes BA; Sigaloff KCE; Spoorenberg V; Stijnis C; Bonten MJM; van der Meer JTM
Clin Infect Dis; 2024 Apr; 78(4):846-854. PubMed ID: 38157401
[TBL] [Abstract][Full Text] [Related]
42. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease.
Kang CK; Kwak YG; Park Y; Song KH; Kim ES; Jung SI; Park KH; Park WB; Kim NJ; Kim YK; Jang HC; Lee S; Jeon JH; Kwon KT; Kim CJ; Kim YS; Kim HB;
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1119-1123. PubMed ID: 29667110
[TBL] [Abstract][Full Text] [Related]
43. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP).
Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2022 Dec; 46():. PubMed ID: 36529133
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
45. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
Kufel WD; Parsels KA; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
Pharmacotherapy; 2023 Jan; 43(1):15-23. PubMed ID: 36371648
[TBL] [Abstract][Full Text] [Related]
46. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
[TBL] [Abstract][Full Text] [Related]
47. Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa.
Fortuin-de Smidt MC; Singh-Moodley A; Badat R; Quan V; Kularatne R; Nana T; Lekalakala R; Govender NP; Perovic O;
Int J Infect Dis; 2015 Jan; 30():41-8. PubMed ID: 25448331
[TBL] [Abstract][Full Text] [Related]
48. Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children's hospital.
Munro APS; Blyth CC; Campbell AJ; Bowen AC
BMC Infect Dis; 2018 Aug; 18(1):387. PubMed ID: 30097020
[TBL] [Abstract][Full Text] [Related]
49. Whole genome sequencing and molecular epidemiology of paediatric Staphylococcus aureus bacteraemia.
Campbell AJ; Mowlaboccus S; Coombs GW; Daley DA; Al Yazidi LS; Phuong LK; Leung C; Best EJ; Webb RH; Voss L; Athan E; Britton PN; Bryant PA; Butters CT; Carapetis JR; Ching NS; Francis J; Hung TY; Nourse C; Ojaimi S; Tai A; Vasilunas N; McMullan B; Bowen AC; Blyth CC;
J Glob Antimicrob Resist; 2022 Jun; 29():197-206. PubMed ID: 35342022
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology, antimicrobial resistance and outcomes of
Loftus MJ; Young-Sharma TEMW; Wati S; Badoordeen GZ; Blakeway LV; Byers SMH; Cheng AC; Jenney AWJ; Naidu R; Prasad A; Prasad V; Tudravu L; Vakatawa T; van Gorp E; Wisniewski JA; Rafai E; Stewardson AJ; Peleg AY
Lancet Reg Health West Pac; 2022 May; 22():100438. PubMed ID: 35373162
[TBL] [Abstract][Full Text] [Related]
51. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia.
Patel D; Brown ML; Edwards S; Oster RA; Stripling J
Int J Antimicrob Agents; 2023 Mar; 61(3):106735. PubMed ID: 36690124
[TBL] [Abstract][Full Text] [Related]
52. Are we missing the Staphylococcus aureus bacteraemia forest for the MRSA trees?
Laupland KB
Infect Dis (Lond); 2018 Jan; 50(1):59-61. PubMed ID: 29161941
[TBL] [Abstract][Full Text] [Related]
53. Paediatric Staphylococcus aureus bacteraemia: A single-centre retrospective cohort.
Roediger JC; Outhred AC; Shadbolt B; Britton PN
J Paediatr Child Health; 2017 Feb; 53(2):180-186. PubMed ID: 27566273
[TBL] [Abstract][Full Text] [Related]
54. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
Britt NS; Patel N; Shireman TI; El Atrouni WI; Horvat RT; Steed ME
J Antimicrob Chemother; 2017 Feb; 72(2):535-542. PubMed ID: 27999028
[TBL] [Abstract][Full Text] [Related]
55. Performance of Risk Scores in Predicting Infective Endocarditis in Patients with
Ngiam JN; Koh MCY; Archuleta S; Fisher D; Chai LY; Sia CH; Kong WKF; Tambyah PA
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792488
[No Abstract] [Full Text] [Related]
56. Does extraction of cardiac implantable electronic devices improve outcome in patients with
Snygg-Martin U; Ruus C; Skovbjerg S; Studahl M; Andersson LM
Infect Dis (Lond); 2020; 52(12):877-882. PubMed ID: 32735155
[TBL] [Abstract][Full Text] [Related]
57. Epidemiology and clinical presentation of community-acquired Staphylococcus aureus bacteraemia in children under 5 years of age admitted to the Manhiça District Hospital, Mozambique, 2001-2019.
Garrine M; Quintó L; Costa SS; Messa A; Massinga AJ; Vubil D; Nhampossa T; Massora S; Ácacio S; Cossa A; Sigaúque B; Bassat Q; Couto I; Mandomando I
Eur J Clin Microbiol Infect Dis; 2023 May; 42(5):653-659. PubMed ID: 36932278
[TBL] [Abstract][Full Text] [Related]
58. High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant
Kawasuji H; Ikezawa Y; Morita M; Sugie K; Somekawa M; Ezaki M; Koshiyama Y; Takegoshi Y; Murai Y; Kaneda M; Kimoto K; Nagaoka K; Niimi H; Morinaga Y; Yamamoto Y
Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887217
[TBL] [Abstract][Full Text] [Related]
59. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018.
Coombs GW; Daley DA; Mowlaboccus S; Lee YT; Pang S;
Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178604
[TBL] [Abstract][Full Text] [Related]
60. Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteraemia: a cohort study.
Kim CJ; Song KH; Park KH; Kim M; Choe PG; Oh MD; Lee SH; Jang HC; Kang SJ; Kim HY; Cheon S; Kwak YG; Choi HJ; Kwon KT; Jeon JH; Kim ES; Kim HB;
Clin Microbiol Infect; 2019 Jun; 25(6):723-732. PubMed ID: 30287412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
